VF
MITO

Virtu Financial’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Virtu Financial’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,291
Closed -$25K – 2500
2022
Q2 		$25K Buy
+100,291
New +$34.5K ﹤0.01% 1293
2021
Q1 		– Sell
-44,337
Closed -$67K – 2236
2020
Q4 		$67K Buy
+44,337
New +$62.2K 0.01% 1164

Other funds holding MITO

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Virtu Financial's MITO Position: Q3 2022 in Review

Virtu Financial sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q3 2022, closing a stake of 100,291 shares — an estimated $25K sold.

Virtu Financial first reported a position in MITO in Q4 2020 and held it in 2 quarters. The position peaked at $67K in Q4 2020. 12 funds tracked by Wall St. Rank hold MITO as of Q3 2022.

  • Virtu Financial reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 100,291 Stealth BioTherapeutics Corp. ADS shares in Q3 2022, an estimated $25K.
  • Virtu Financial first reported a position in Stealth BioTherapeutics Corp. ADS in Q4 2020 and held it in 2 quarters.
  • Virtu Financial's Stealth BioTherapeutics Corp. ADS position peaked at $67K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.